Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Xenon Pharmaceuticals PE Ratio 2012-2019 | XENE

Current and historical p/e ratio for Xenon Pharmaceuticals (XENE) from 2012 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Xenon Pharmaceuticals PE ratio as of July 19, 2019 is 0.00.
Xenon Pharmaceuticals PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-07-19 10.02 0.00
2019-03-31 10.16 $-1.79 0.00
2018-12-31 6.31 $-1.58 0.00
2018-09-30 13.20 $-1.74 0.00
2018-06-30 9.20 $-1.54 0.00
2018-03-31 4.90 $-1.50 0.00
2017-12-31 2.83 $-1.72 0.00
2017-09-30 2.95 $-1.59 0.00
2017-06-30 3.15 $-1.67 0.00
2017-03-31 4.00 $-1.68 0.00
2016-12-31 7.70 $-1.48 0.00
2016-09-30 8.10 $-1.43 0.00
2016-06-30 5.90 $-1.19 0.00
2016-03-31 6.99 $-0.84 0.00
2015-12-31 8.04 $-0.91 0.00
2015-09-30 8.26 $0.93 8.88
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.258B $0.000B
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of medicines through the application of its proprietary discovery platform, which it refer to as Extreme Genetics. Xenon is developing proprietary product candidates for the treatment of both orphan as well as more prevalent diseases. The company offers Glybera (R), a gene therapy for the treatment of lipoprotein lipase deficiency, an orphan disorder. Xenon Pharmaceuticals Inc. is headquartered in Burnaby, Canada.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $109.508B 12.38
Gilead Sciences (GILD) United States $85.686B 10.40
Celgene (CELG) United States $64.115B 10.86
Vertex Pharmaceuticals (VRTX) United States $45.613B 55.14
Biogen (BIIB) United States $45.028B 8.55
Illumina (ILMN) United States $43.887B 50.86
CSL (CSLLY) Australia $36.043B 0.00
Regeneron Pharmaceuticals (REGN) United States $33.120B 15.57
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $27.639B 15.64
Incyte (INCY) United States $17.436B 70.70
Exact Sciences (EXAS) United States $15.096B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.897B 0.00
SINO PHARMACEUT (SBMFF) China $14.154B 0.00
Seattle Genetics (SGEN) United States $12.394B 0.00
Sarepta Therapeutics (SRPT) United States $11.244B 0.00
Genmab (GNMSF) Denmark $11.046B 56.15
Array BioPharma (ARRY) United States $10.373B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.283B 49.21
QIAGEN (QGEN) Netherlands $8.989B 29.53
Galapagos (GLPG) Belgium $8.915B 0.00
Guardant Health (GH) United States $8.160B 0.00
Bio-Techne Corp (TECH) United States $8.121B 55.41
Alnylam Pharmaceuticals (ALNY) United States $8.085B 0.00
Bluebird Bio (BLUE) United States $7.786B 0.00
Exelixis (EXEL) United States $6.678B 17.02
Amarin (AMRN) Ireland $6.250B 0.00
BeiGene (BGNE) Cayman Islands $5.802B 0.00
Ascendis Pharma (ASND) Denmark $4.892B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.842B 0.00
Blueprint Medicines (BPMC) United States $4.799B 0.00
Moderna (MRNA) United States $4.692B 0.00
Horizon Pharma Public (HZNP) Ireland $4.554B 11.73
Repligen (RGEN) United States $4.146B 103.28
Mirati Therapeutics (MRTX) United States $3.817B 0.00
Alkermes (ALKS) Ireland $3.810B 0.00
Spark Therapeutics (ONCE) United States $3.771B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.770B 0.00
China Biologic Products (CBPO) China $3.686B 23.41
Ultragenyx Pharmaceutical (RARE) United States $3.590B 0.00
MorphoSys AG (MOR) Germany $3.514B 0.00
Arena Pharmaceuticals (ARNA) United States $3.071B 6.24
Amicus Therapeutics (FOLD) United States $3.053B 0.00
Immunomedics (IMMU) United States $2.931B 0.00
UniQure (QURE) Netherlands $2.819B 0.00
Medicines (MDCO) United States $2.740B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.631B 0.00
Reata Pharmaceuticals (RETA) United States $2.613B 0.00
MyoKardia (MYOK) United States $2.467B 0.00
Halozyme Therapeutics (HALO) United States $2.443B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $2.260B 0.00
Acceleron Pharma (XLRN) United States $2.260B 0.00
Ligand Pharmaceuticals (LGND) United States $2.259B 18.71
Emergent Biosolutions (EBS) United States $2.258B 19.61
NeoGenomics (NEO) United States $2.245B 147.00
Intercept Pharmaceuticals (ICPT) United States $2.135B 0.00
Zai Lab (ZLAB) China $2.087B 0.00
Genomic Health (GHDX) United States $2.083B 44.24
Akcea Therapeutics (AKCA) United States $2.047B 0.00
Denali Therapeutics (DNLI) United States $1.986B 0.00
Myriad Genetics (MYGN) United States $1.958B 19.47
REGENXBIO (RGNX) United States $1.826B 0.00
Insmed (INSM) United States $1.699B 0.00
Cambrex (CBM) United States $1.534B 19.40
Fate Therapeutics (FATE) United States $1.467B 0.00
RA PHARMCTL INC (RARX) United States $1.457B 0.00
AnaptysBio (ANAB) United States $1.432B 0.00
Sangamo Therapeutics (SGMO) United States $1.402B 0.00
Innoviva (INVA) United States $1.368B 3.78
Athenex (ATNX) United States $1.307B 0.00
Alector (ALEC) United States $1.291B 0.00
Coherus BioSciences (CHRS) United States $1.254B 0.00
Editas Medicine (EDIT) United States $1.214B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.189B 0.00
Epizyme (EPZM) United States $1.161B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.078B 0.00
Codexis (CDXS) United States $1.028B 0.00
Cara Therapeutics (CARA) United States $1.007B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.001B 0.00
ANI Pharmaceuticals (ANIP) United States $0.976B 17.31
Twist Bioscience (TWST) United States $0.976B 0.00
Zymeworks (ZYME) Canada $0.960B 0.00
Principia Biopharma (PRNB) United States $0.957B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.911B 0.00
Retrophin (RTRX) United States $0.886B 0.00
Adverum Biotechnologies (ADVM) United States $0.878B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.856B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.844B 0.00
Vericel (VCEL) United States $0.841B 0.00
WAVE Life Sciences (WVE) Singapore $0.825B 0.00
Arvinas (ARVN) United States $0.791B 0.00
Intellia Therapeutics (NTLA) United States $0.787B 0.00
Precision BioSciences (DTIL) United States $0.746B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.705B 33.28
Zealand Pharma (ZEAL) Denmark $0.691B 8.07
Zealand Pharma (ZLDPF) Denmark $0.683B 0.00
Intra-Cellular Therapies (ITCI) United States $0.649B 0.00
Cytokineticsorporated (CYTK) United States $0.648B 0.00
Cellectis S.A (CLLS) France $0.634B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.631B 0.00
Heska (HSKA) United States $0.626B 64.12
Clovis Oncology (CLVS) United States $0.613B 0.00
DBV Technologies S.A (DBVT) France $0.606B 0.00
Stemline Therapeutics (STML) United States $0.604B 0.00
Anika Therapeutics (ANIK) United States $0.584B 19.94
Lexicon Pharmaceuticals (LXRX) United States $0.566B 0.00
Revance Therapeutics (RVNC) United States $0.566B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.560B 0.00
CytomX Therapeutics (CTMX) United States $0.555B 0.00
Pharming Group (PHGUF) Netherlands $0.521B 0.00
MiMedx (MDXG) United States $0.516B 0.00
Mesoblast (MESO) Australia $0.493B 0.00
UROGEN PHARMA (URGN) United States $0.447B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.442B 0.00
PHARMA MAR SA (PHMMF) Spain $0.441B 0.00
Puma Biotechnology (PBYI) United States $0.407B 0.00
Prothena (PRTA) Ireland $0.399B 0.00
PDL BioPharma (PDLI) United States $0.384B 9.17
Arcus Biosciences (RCUS) United States $0.380B 0.00
Biofrontera AG (BFRA) Germany $0.373B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
AC Immune SA (ACIU) Switzerland $0.370B 23.83
Gritstone Oncology (GRTS) United States $0.368B 0.00
Bellus Health (BLUSF) Canada $0.362B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.360B 0.00
Scholar Rock Holding (SRRK) United States $0.359B 0.00
Starpharma Holdings (SPHRY) Australia $0.355B 0.00
Avid Bioservices (CDMO) United States $0.351B 0.00
Albireo Pharma (ALBO) United States $0.350B 0.00
Merus (MRUS) Netherlands $0.341B 0.00
Agenus (AGEN) United States $0.340B 0.00
Kadmon Holdings (KDMN) United States $0.338B 0.00
BioDelivery Sciences (BDSI) United States $0.337B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.336B 0.00
Prometic Life Sciences (PFSCD) Canada $0.335B 0.00
Acorda Therapeutics (ACOR) United States $0.332B 5.84
Senesco Technologies (ELOX) United States $0.331B 0.00
Theratechnologies (THERF) Canada $0.331B 0.00
Syros Pharmaceuticals (SYRS) United States $0.321B 0.00
Sorrento Therapeutics (SRNE) United States $0.316B 0.00
Protagonist Therapeutics (PTGX) United States $0.311B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.304B 0.00
Cellular Biomedicine (CBMG) United States $0.287B 0.00
Inovio Pharmaceuticals (INO) United States $0.282B 0.00
Kindred Biosciences (KIN) United States $0.262B 0.00
Sutro Biopharma (STRO) United States $0.256B 0.00
PHASEBIO PHARMA (PHAS) United States $0.254B 0.00
ChromaDex (CDXC) United States $0.248B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.245B 0.00
Kamada (KMDA) Israel $0.240B 9.33
Dynavax Technologies (DVAX) United States $0.238B 0.00
Geron (GERN) United States $0.233B 0.00
ADMA Biologics Inc (ADMA) United States $0.224B 0.00
Athersys (ATHX) United States $0.223B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.222B 0.00
CorMedix Inc (CRMD) United States $0.215B 0.00
Palatin Technologies (PTN) United States $0.214B 0.00
Cel-Sci (CVM) United States $0.212B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.202B 0.00
Five Prime Therapeutics (FPRX) United States $0.202B 0.00
MannKind (MNKD) United States $0.201B 0.00
Cerecor (CERC) United States $0.198B 0.00
Affimed (AFMD) Germany $0.197B 0.00
Abeona Therapeutics (ABEO) United States $0.189B 0.00
Pfenex (PFNX) United States $0.188B 0.00
OSMOTICA PHARM (OSMT) United States $0.187B 0.00
Mersana Therapeutics (MRSN) United States $0.186B 0.00
POXEL SA FRANCE (PXXLF) $0.184B 0.00
Synlogic (SYBX) United States $0.183B 0.00
Arsanis (XFOR) United States $0.182B 0.00
Spero Therapeutics (SPRO) United States $0.179B 0.00
Enzo Biochem (ENZ) United States $0.178B 0.00
Compugen (CGEN) Israel $0.174B 0.00
BioTime (BTX) United States $0.171B 11.40
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Nicox SA (NICXF) France $0.162B 0.00
XOMA (XOMA) United States $0.161B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.156B 0.00
Cue Biopharma (CUE) United States $0.154B 0.00
Strongbridge Biopharma (SBBP) United States $0.153B 8.81
Liquidia Technologies (LQDA) United States $0.144B 0.00
OvaScience (MLND) United States $0.143B 0.00
Adocia (ADOCY) France $0.140B 0.00
TOCAGEN INC (TOCA) United States $0.140B 0.00
Celyad SA (CYAD) Belgium $0.139B 0.00
Dyadic (DYAI) United States $0.136B 0.00
Northwest Biotherapeutics (NWBO) United States $0.129B 0.00
Seres Therapeutics (MCRB) United States $0.129B 0.00
Aptinyx (APTX) United States $0.127B 0.00
Alcobra (ARCT) United States $0.125B 0.00
NantKwest (NK) United States $0.124B 0.00
Aduro Biotech (ADRO) United States $0.118B 0.00
Verastem (VSTM) United States $0.117B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.116B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.112B 0.00
Arbutus Biopharma (ABUS) Canada $0.111B 0.00
Novavax (NVAX) United States $0.109B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.105B 0.00
Menlo Therapeutics (MNLO) United States $0.104B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.103B 0.00
Checkpoint Therapeutics (CKPT) United States $0.102B 0.00
Catalyst Biosciences (CBIO) United States $0.101B 0.00
SESEN BIO, INC (SESN) United States $0.098B 0.00
Trevena (TRVN) United States $0.094B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.091B 0.00
Pluristem Therapeutics (PSTI) Israel $0.087B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.084B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.083B 0.00
Fortress Biotech (FBIO) United States $0.082B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.080B 0.00
Unum Therapeutics (UMRX) United States $0.080B 0.00
Selecta Biosciences (SELB) United States $0.077B 0.00
AquaBounty Technologies (AQB) United States $0.076B 0.00
Curis (CRIS) United States $0.075B 0.00
VBI Vaccines (VBIV) United States $0.075B 0.00
Orgenesis (ORGS) United States $0.073B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.073B 0.00
Idera Pharmaceuticals (IDRA) United States $0.073B 0.00
Signal Genetics (MGEN) United States $0.072B 0.00
VTv Therapeutics (VTVT) United States $0.071B 0.00
Applied Genetic Technologies (AGTC) United States $0.071B 38.80
Oncobiologics (OTLK) United States $0.069B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.066B 0.00
Organovo Holdings (ONVO) United States $0.063B 0.00
Alimera Sciences (ALIM) United States $0.061B 0.00
Antibe Therapeutics (ATBPF) Canada $0.060B 0.00
ARAVIVE, INC (ARAV) United States $0.060B 0.00
Prima BioMed (IMMP) Australia $0.059B 0.00
NewLink Genetics (NLNK) United States $0.058B 0.00
Protalix BioTherapeutics (PLX) Israel $0.057B 0.00
Invo BioScience (IVOB) United States $0.053B 0.00